本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

AROA BIOSURGERY LTD

0.615
+0.0050.82%
成交量:5.69萬
成交額:3.48萬
市值:2.12億
市盈率:-60.67
高:0.620
開:0.605
低:0.605
收:0.610
52周最高:0.815
52周最低:0.350
股本:3.45億
流通股本:2.59億
量比:0.31
換手率:0.02%
股息:- -
股息率:- -
每股收益(TTM):-0.010
每股收益(LYR):-0.010
淨資產收益率:-4.06%
總資產收益率:-1.66%
市淨率:2.50
市盈率(LYR):-60.92

資料載入中...

公司資料

公司名字:
AROA BIOSURGERY LTD
交易所:
ASX
成立時間:
2007
員工人數:
- -
公司地址:
64 Richard Pearse Drive,Airport Oaks,Mangere,Auckland,New Zealand
郵編:
2022
電話:
傳真:
- -
簡介:
Aroa Biosurgery Limited designs and manufactures medical products, which enable surgeons and clinicians to repair serious tissue injuries. It offers Endoform, a high performance building block for developing a range of regenerative tissue substitutes to assist with tissue repair and healing; Endoform Dermal Template, an intact extracellular matrix to treat acute and chronic wounds from day one; and Reinforced Bioscaffolds, a surgical product that is primarily designed for use in ventral hernia repair and abdominal wall reconstruction. The company's products are distributed through medical technology companies. Aroa Biosurgery Limited was formerly known as Mesynthes Ltd. and changed its name to Aroa Biosurgery Limited in June 2015. The company was founded in 2007 and is based in Auckland, New Zealand.